Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.41 USD | -7.34% | -16.22% | -63.37% |
Business Summary
Number of employees: 40
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 58 | 13-07-04 | |
Sandra Boenisch
DFI | Director of Finance/CFO | 43 | 15-09-30 |
Edward Hammond
CTO | Chief Tech/Sci/R&D Officer | - | - |
Walter Kaufmann
CTO | Chief Tech/Sci/R&D Officer | - | 19-01-01 |
Stephan Toutain
COO | Chief Operating Officer | - | 18-03-04 |
David Goldberger
LAW | General Counsel | - | Nov. 05 |
Adebayo Laniyonu
PRN | Corporate Officer/Principal | - | 21-05-04 |
Daniel Klamer
PRN | Corporate Officer/Principal | - | 15-08-31 |
Juliana Daley
PRN | Corporate Officer/Principal | 37 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 58 | 13-07-04 | |
Tom Skarpelos
FOU | Founder | 57 | 04-01-22 |
Jiong Ma
CHM | Chairman | 60 | 21-05-24 |
Steffen Thomas
BRD | Director/Board Member | 58 | 15-06-14 |
Peter Donhauser
BRD | Director/Board Member | 58 | 17-02-07 |
Director/Board Member | 51 | 18-03-01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 82,112,511 | 79,530,715 ( 96.86 %) | 0 | 96.86 % |
Company contact information
Anavex Life Sciences Corp.
630 5th Avenue 20th floor
10111, New York
+844 689 3939
http://www.anavex.comSector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-63.37% | 302M | |
-1.51% | 105B | |
+3.22% | 97.5B | |
+1.86% | 22.19B | |
-16.53% | 21.33B | |
-8.49% | 18.68B | |
-42.33% | 16.6B | |
-20.09% | 14.52B | |
+5.47% | 14.09B | |
+28.85% | 10.99B |
- Stock Market
- Equities
- AVXL Stock
- Company Anavex Life Sciences Corp.